Healthcare Sector

Weight-loss drugs are changing everything

Novo's series of unfortunate events

Eli wins this round, while Novo continues to flounder.

No silver bullet for Novo

Shares sank on the news.

Healthcare stocks feel the pain

The end of the government shutdown is the beginning of problems for healthcare stocks.

Big pharma, big fight

The two pharma companies are duking it out for the future of weight-loss drugs.

Will cheaper weight-loss drugs slim down stocks?

President Trump's unplanned remarks took a toll on Novo Nordisk and Eli Lilly.

Slimming down is big business

Both pharma giants are working to create new obesity pills.